Nutranomics Completes GenEpic™ Prostate Cancer Human Clinical Study Due …

Nutranomics Completes GenEpic™ Prostate Cancer Human Clinical Study Due …

Dr. Gibbs concluded, "Because GenEpic™ is intended to act as an ATP inhibitor, we are hopeful that the study will show that it is effective for treating prostate cancer, and that it could also be effective to treat many other types of rapidly growing

(Visited 1 times, 1 visits today)
4
Like
Save

Comments

Comments are disabled for this post.